Search
SOLACI Congress
HomeStructural heart diseaseValvular Aortic valve

Valvular Aortic valve

View Category

Medtronic educational sessions

Clinical Impact of Paravalvular Regurgitation After TAVR

Clinical Impact of Paravalvular Regurgitation After TAVR. Presenters: -Fernando Cura (Argentina).  -Gabriel Maluenda (Chile). This video, sponsored and funded by Medtronic,...
solaci -
Learn More
Medtronic educational sessions

Percutaneous Interventions After TAVR.

Percutaneous Interventions After TAVR. Presenters: -Dr. Matías Stejfman. -Dr. Gabriel Maluenda. This video, sponsored and funded by Medtronic, was filmed during SOLACI-CACI 2017...
solaci -
Learn More
Medtronic educational sessions

TAVR as a Minimalist Procedure

TAVR as a Minimalist Procedure. Presenters: Dr. Paulo Caramori, Brasil.  Dr. Luis Gutierrez Jaikel. This video, sponsored and funded by Medtronic,...
solaci -
Learn More
Structural heart disease

Development of New Valves Lowers Need for Pacemaker

Courtesy of Dr. Carlos Fava. While the benefits of TAVR are well-known, the need for a permanent pacemaker after...
solaci -
Learn More
Structural heart disease

The Perks of Conscious Sedation in TAVR

The main advantage of transcatheter aortic valve replacement (TAVR) has always been its less invasive nature, compared against surgery....
solaci -
Learn More
Structural heart disease

TAVR in Pure Aortic Regurgitation: New Devices, New Outcomes

Pure aortic regurgitation has historically been considered a contraindication for transcatheter aortic valve replacement (TAVR) due to...
solaci -
Learn More
Structural heart disease

Cardiac Damage: Should we start to assess it?

Courtesy of Dr. Carlos Fava. The current recommendation for  aortic valve replacement is based on stenosis severity based on...
solaci -
Learn More
Structural heart disease

Failing Surgical Bioprosthesis: A Challenge on the Rise

Courtesy of Dr. Carlos Fava. The gold standard for failing aortic bioprosthesis has traditionally been surgery. However, since...
solaci -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

AHA 2024 | VANISH2 Trial

Dr. Omar Tupayachi - 0
Cardiac defibrillator implants (CDIs) have been shown to improve survival in patients with ischemic cardiomyopathy and ventricular tachycardia (VT). However, approximately one third of...

AHA 2024 | SUMMIT

Dr. Omar Tupayachi - 0
It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

AHA 2024 – BPROAD

Dr. Omar Tupayachi - 0
Hypertension (elevated blood pressure, BP) is the most common comorbidity among diabetic patients and has been associated with higher cardiovascular risk, though as a...

Institutional News

Check out the best images of the El Salvador 2024 Sessions

solaci - 0
Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

solaci - 0
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

solaci - 0
Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy